Mon, Oct 20, 2014, 10:54 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Avanir Pharmaceuticals, Inc. Message Board

  • woods80513 woods80513 Dec 19, 2011 3:55 PM Flag


    I know the day's not over but let's go ahead and see how The Great Predictor, harryclown, did today in his predictions.

    Harry went into the day batting 3 for 38; slightly behind the blind man using the dart board.

    Mid-day AVNR was up nicely, near 10% up, when harry came out from under his rock and made the bold statement, "we're due for a run!". He also informed we'd be in for higher volume.

    Within minutes the PPS tanked down about 7%.

    (You're 0 for 1 on the day harry).

    Just after harry's prediction about volume the volumn all but shut down, became anemic to say the least for the rest of the day.

    (0 for Deuce, harry)

    It was also about mid-day when the Great Harry once again issued the 'Buy' recommendation for his other loser SVNT. SVNT immediately dropped about 3% and looks to finish out the day down again. Note that harry encouraged us to buy this POS several months ago when it was $3.35 - now struggling to stay above $2.

    (sorry harry, 0 for 3)

    Later in the day harry makes his 4th and final call for the day. "We're going back up - back up to re-test 1.97 (the HOD)". At which point AVNR dropped another 3%. LOL.

    0 for 4. Bringing the harryclown's batting average now to 3 for 42.

    Better luck next time, harry. And for the record, harry, for now on let's make the predictions BEFORE the event happens, ok? No more of this predicting a 'run' when the things already up 10%.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
11.68+0.76(+6.96%)Oct 20 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.